Abstract:Background
There are limited data on Coronavirus disease 2019 (COVID-19) in solid organ transplant patients, especially in heart transplant recipients, with only a few case reports and case series described so far. Heart transplant recipients may be at particular high risk due to their comorbidities and immunosuppressed state.
Case presentation
This report describes the clinical course and the challenging management of early COVID-19 infection in t… Show more
“…Five databases were used to find 2818 articles related to COVID-19 infection in HT and heart-kidney transplant recipients. Thirty-three studies were then deemed eligible for inclusion in this review [ 7 – 39 ]. A PRISMA flow diagram detailing the process of identification, inclusion, and exclusion of studies is shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Of the thirty-three studies, eleven were retrospective case series [ 7 , 11 , 14 , 19 , 20 , 26 , 29 – 33 , 38 , 39 ], while twenty-two were case reports [ 8 – 10 , 12 , 13 , 15 – 18 , 21 – 25 , 27 , 28 , 34 – 37 ]. All were peer-reviewed.…”
“…Five databases were used to find 2818 articles related to COVID-19 infection in HT and heart-kidney transplant recipients. Thirty-three studies were then deemed eligible for inclusion in this review [ 7 – 39 ]. A PRISMA flow diagram detailing the process of identification, inclusion, and exclusion of studies is shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Of the thirty-three studies, eleven were retrospective case series [ 7 , 11 , 14 , 19 , 20 , 26 , 29 – 33 , 38 , 39 ], while twenty-two were case reports [ 8 – 10 , 12 , 13 , 15 – 18 , 21 – 25 , 27 , 28 , 34 – 37 ]. All were peer-reviewed.…”
“…While the literature for adult patients with heart transplants is limited to case reports and small case series, there is some suggestion that infection early after transplant may have an impact on outcomes ( 20 , 21 , 22 ). A US cohort of 28 adult heart transplant patients reported a 25% case fatality rate ( 15 ).…”
Section: Discussionmentioning
confidence: 99%
“…However, one-fifth of the patients were <1 year post transplant with one death in this group. This is an important group of patients to continue to monitor, given the reports of adults experiencing worse outcomes in the early phase post HTx ( 20 , 21 , 22 ) Whether reduction in immunosuppression is warranted in this specific group of patients is unclear.…”
“… [28] Lima et al, showed negative impact of COVID-19 in five heart transplants. [29] Tchana-Sato et al reported two fatalities in perioperative COVID-19 heart transplantation with COVID-19 [30] Keller et al detailed a deceased donor lung transplant who acquired early covid-19 required mechanical ventilation. [31] Dale et al described two cases of early liver transplant who contracted severe COVID-19 and recovered.…”
Introduction:
Limited data exists on the incidence and outcome of early coronavirus disease (COVID-19) in kidney transplantation recipients (KTR).
Methods:
A retrospective multicentre research was conducted across 12 centers of India. We explored the symptomatology, demographic, laboratory findings and outcome of COVID-19 within 30 days of transplantation. The outcome was compared with the overall KTR and waitlisted patients acquiring COVID-19.
Results:
The incidence of early COVID-19 was 2.6% (n =22) for the cumulative 838 renal transplants performed since nationwide lockdown in March 2020 till May 2021. Overall, 1049 KTR were diagnosed with COVID-19 and 2% of those had early COVID-19. The median age of the early COVID-19 cohort was 43(31-46) years. COVID-19 severity ranged from asymptomatic (18.2%), mild (59.1%), moderate (9.1%) and severe (13.6%). Among clinical symptoms, Dyspnea and Anosmia were frequent and in laboratory parameters neutrophil lymphocyte ratio, high sensitive C reactive protein and D- dimer were higher in patients requiring oxygen. The mortality in early COVID-19 was not higher than overall KTR (4.5% vs 8.5%; p-value: 1). COVID-19 severity (23.9% vs 15.7%; p-value: 0.0001) and mortality (15.5% vs 8.5%; p-value: 0.001) among waitlisted patients (n = 1703) were higher compared to overall KTR.
Conclusion:
We report higher burden of COVID-19 in waitlisted patients compared to KTR and a favorable outcome in early COVID-19 in KTR. Our report will help the transplant physicians in dealing with the ongoing dilemma of halting or resuming transplantation in the COVID-19 era.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.